Table 2.
Properties
|
MSCs
|
ESCs
|
iPSCs
|
Sources | Perinatal and adult tissues | Embryo at blastocyst stage | Genetically reprogrammed specialized cells |
Plasticity | Multipotent | Pluripotent | Pluripotent |
Teratoma formation | No | Yes | Yes |
Growth | Limited | High | High |
Ethical concerns | No | Yes | No |
Immune rejection | No | Yes | No |
Cell transplantation | Autologous and allogenic | Allogenic | Autologous |
Clinical trials in human patients | Ongoing | Limited | In vitro/in vivo only |
Use in genetic disorder | Deficient (Carry mutated gene) | Superior | Deficient (Carry mutated gene) |
Ease of isolation | Yes | No | No |
MSCs: Mesenchymal stem cells; ESCs: Embryonic stem cells; iPSCs: Induced pluripotent stem cells.